Health Care/Hospital News & Press Release Distribution

Health Care/Hospital

APAC
Global

2023 ASCO | Multi-center Data for Combination Study of GenFleet's GFH018 (TGF-β R1 inhibitor) with Anti-PD-1 Antibody Demonstrates Significant Potential to Enhance Efficacy of Immune Checkpoint Inhibitors among ICI-naïve Patients

SHANGHAI and CHICAGO, June 6, 2023 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, today published the latest results from the phase Ib/II study of GFH018 (TGF-β R1 inhibitor) with toripalimab（anti-PD-1 ...

2023-06-06 19:00 1875

Samsung Biologics accelerates timeline of new fifth plant to be operational by April 2025

- Marking the first phase of the company's second Bio Campus, Plant 5 is expected to have shortest construction timeline - Samsung Biologics will maintain the world's largest biomanufacturing capacity at 784,000 liters upon completion of the newest plant - Key features of Plant 5 include seamless ...

2023-06-06 19:00 1956

Acepodia Secures $100 Million Series D Financing to Advance

First-In-Class Cell Therapies with Antibody-Cell Conjugation (ACC) Platform Series D led by Digital Mobile Venture with participation from additional existing investors Funds will support expansion and progress of oncology pipeline, including ACE1831 and ACE2016, antibody armed allogeneic gamma ...

2023-06-06 18:00 1679

Midea Healthcare Unveils New Solutions for Smart Healthcare Market

FOSHAN, China, June 6, 2023 /PRNewswire/ -- Midea Healthcare, as one of primarily business for Midea Group (000333.SZ), recently held a new product launch event in CMEF 2023 with its five medical industry consortia – Wandong (WDM), KUKA, Midea Biomedical, Swisslog Healthcare, and Midea Building ...

2023-06-06 16:10 2551

Midea Healthcare Unveils New Solutions for Smart Healthcare Market

Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer

SINGAPORE, June 6, 2023 /PRNewswire/ -- Jun. 1st, 2023, Biosyngen Pte. Ltd. (hereinafter as "Biosyngen") announced that the U.S. Food and Drug Administration's (FDA) Office of Orphan Products Development (OOPD) has granted to its application, for immune cell therapy BRG01for the treatment of nas...

2023-06-06 12:58 2498

Biosyngen's Cell Therapy BRG01 Granted Orphan Drug Designation by the U.S. FDA for Treatment of Nasopharyngeal Cancer

Live from ASCO 2023 | Ascentage Pharma Releases Updated Data Showing APG-2449's Potential as a New Treatment for Drug-Resistant NSCLC

SUZHOU, China and ROCKVILLE, Md., June 6, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that for the second consecutive year, it has release...

2023-06-06 12:20 3047

Europ Assistance announces the acquisition of several AXA Partners assistance businesses in Asia-Pacific, continuing its expansion in a strategic region

HONG KONG, June 6, 2023 /PRNewswire/ -- Europ Assistance announced today the acquisition from AXA Partners[1] of its assistance businesses in Hong Kong, Malaysia, Thailand, Japan, and Taiwan. With these acquisitions, Europ Assistance confirms the importance of this region to its sustainable growt...

2023-06-06 12:00 3084

USANA Malaysia Named Top Combination Dietary Supplements Brand by Euromonitor International

USANA Malaysia awarded for fifth year in a row KUALA LUMPUR, Malaysia, June 6, 2023 /PRNewswire/ -- USANA Malaysia was recently awarded the title Top #1 Combination Dietary Supplements Brand in Malaysia by market research giant Euromonitor International—earning this elite recognition for the fift...

2023-06-06 11:00 2279

Live from ASCO 2023 | Ascentage Pharma Releases the First Dataset of Lisaftoclax in WM, Revealing Encouraging Therapeutic Potential

SUZHOU, China and ROCKVILLE, Md,, June 5, 2023 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released preliminary results from a Phas...

2023-06-06 10:45 2022

Alphamab Oncology updated clinical research data for KN026 in Combination with KN046 in HER2-Positive Solid Tumors at the ASCO 2023 annual meeting

* As of November 10, 2022, 26 patients with HER2-positive unresectable or metastatic solid tumors (other than breast cancer and gastric/gastroesophageal junction cancer) were enrolled, 92.3% of whom had received ≥2L prior systemic therapy. The objective response rate (ORR) was 53.8% with 6.8 mo...

2023-06-06 09:06 2191

Telix to Present at Jefferies Healthcare Conference

MELBOURNE, Australia, June 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that DrChristian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare Conference being held inNew York from June 7 to June 9, 2023...

2023-06-06 08:40 2039

Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting

SUZHOU, China, June 6, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, has presented updated data of C...

2023-06-06 08:20 2394

Scientific Research Report Highlights Medit i700 wireless, Medit i700, and Medit i600 as Top Intraoral Scanners in Dentistry

* Dentists Worldwide Choose Medit i700 wireless and Medit i700 as Preferred Scanners * Medit Continues to Drive Innovation in Dental Technology with Award-Winning Scanners SEOUL, South Korea and LONG BEACH, Calif., June 6, 2023 /PRNewswire/ -- A recent transnational questionnaire study conduc...

2023-06-06 08:00 3482

Scientific Research Report Highlights Medit i700 wireless, Medit i700, and Medit i600 as Top Intraoral Scanners in Dentistry

Innovent Presents Phase 1 Clinical Data of IBI351 (KRASG12C Inhibitor) as Monotherapy for Metastatic Colorectal Cancer at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-06-06 08:00 4422

Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-06-06 08:00 3951

Cali Biosciences Initiates Second Phase III Study of CPL-01 (Long-Acting Ropivacaine) to Decrease Post-Operative Pain and Reduce or Eliminate Opioid Use and Presents Consistent and Predictable PK Results Across Multiple Surgeries

* Subjects in Bunionectomy Study Dosed * Data Presented at American Society for Pharmacology and Experimental Therapeutics Shows Similar Ropivacaine Pharmacokinetic Curves From CPL-01 Across Multiple Surgeries; Minimal Variability as Compared to Liposomal Bupivacaine SAN DIEGO, June 5, 2023 ...

2023-06-06 00:00 2379

Russellville Hospital and United Imaging Announce First Installation in the U.S. of the 4 cm uCT(R) ATLAS Computed Tomography Scanner

Russellville Hospital Moved Quickly To Bring High-End Technology to Patients HOUSTON, June 5, 2023 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, confirmed that Russellville Hospital is the first customer to complete installat...

2023-06-05 22:00 1946

Maternity and Baby Brand Momcozy Launches Cutting-edge M5 Wearable Breast Pump - the Ultimate Solution for Busy Moms

NEW YORK, June 5, 2023 /PRNewswire/ -- Momcozy, the renowned maternity and baby brand endorsed by over two million moms globally, has launched thecutting-edge M5 Wearable Breast Pump

2023-06-05 22:00 1992

ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer

YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company, announced the latest clinical research results on disitamab vedotin (RC48) at this year's American Society of Cl...

2023-06-05 21:26 2636

RemeGen Demonstrates Profitability to Successfully Receive Approval from the Hong Kong Stock Exchange to Upgrade Stock Short Name

The "B" marker is removed from the Company's stock short name YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a fully-integrated commercial-stage biotechnology company, successfully obtained approval fro...

2023-06-05 21:17 3408

1 ... 143 144 145146147 148 149 ... 808